What Is the Future of the Medical X-ray Film Market? Growth Forecasts & Insights

According to a newly published market research report by 24LifeSciences, global Medical X-ray Film market is valued at USD 908 million in 2026 and is projected to reach USD 1,090 million by 2034, growing at a compound annual growth rate (CAGR) of 2.7% during the forecast period.

Medical X-ray Film is a specialized light-sensitive material formulated to capture diagnostic images when exposed to X-ray radiation. Despite the widespread adoption of digital radiography, these films remain essential for producing high-resolution, permanent images

Top 10 Key Players Transforming the Global Hydroxyzine Imine Market (2026–2034)

According to a newly published market research report by 24LifeSciences, global Hydroxyzine Imine market was valued at USD 797 million in 2026 and is projected to reach USD 1172 million by 2034, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period.

Hydroxyzine Imine, a critical pharmaceutical intermediate, is the precursor in synthesizing hydroxyzine hydrochloride and hydroxyzine pamoate, which are first-generation antihistamines and central nervous system depressants.

Chemo Graded Nitrile Gloves Market to Reach USD 4.6 Billion by 2034 | Key Trends

According to a newly published market research report by 24LifeSciences, global Chemo Graded Nitrile Powder-free Medical Examination Gloves market is valued at USD 2.8 billion in 2026 and is projected to reach USD 4.6 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period.

Chemo Graded Nitrile Powder-free Medical Examination Gloves are specialty personal protective equipment (PPE) specifically engineered for handling hazardous drugs, particularly cytotoxic agents used in chemotherapy treatments.

Top Healthcare Innovations Reshaping Oral Solid Dosage Contract Manufacturing

According to a newly published market research report by 24LifeSciences, global oral solid dosage contract manufacturing market is valued at USD 75.5 billion in 2026 and is projected to reach USD 117.2 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period.

Oral solid dosage (OSD) contract manufacturing involves outsourcing the production of solid-form pharmaceuticals, such as tablets, capsules, powders, and granules, to specialized third-party organizations.

Next Generation Cancer Diagnostics Market: Innovation-Driven Growth and Future Opportunities

According to a newly published market research report by 24LifeSciences, global next generation cancer diagnostics market was valued at USD 8,060 million in 2026 and is projected to reach USD 28,120 million by 2034, growing at a compound annual growth rate (CAGR) of 20.0% during the forecast period.

Next generation cancer diagnostics represent a paradigm shift from traditional histopathology. These advanced technologies enable highly sensitive and specific analysis of cancer biomarkers from various biological samples.